6/26/2025

DexCom’s first quarter was met with a positive response from the market, as the company delivered revenue ahead of Wall Street expectations and maintained strong growth momentum. Management attributed this performance to robust demand, record new patient additions, and successful navigation of short-term supply challenges. CEO Kevin Sayer highlighted that the company’s expanded commercial reach, recent product launches, and broader patient access were key to driving acceleration in new customer

Source: Yahoo

6/25/2025

Sarah Karlin-Smith of Pink Sheet reported via X: “RFK says HHS about to launch one of the biggest campaigns in HHS history to encourage Americans to use wearable health devices (like CGMs). His vision is every American wearing “wearable” in 4 years.” Shares of companies in the continuous glucose monitoring space moved higher intraday, including Tandem Diabetes (TNDM), DexCom (DXCM), Insulet (PODD), Abbott (ABT) and Medtronic (MDT). Published first on TheFly – the ultimate source for real-time, m

Source: Yahoo

6/25/2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Source: Yahoo

6/25/2025

The United States market has experienced a positive trend, rising 1.9% over the last week and showing a 12% increase over the past year, with earnings forecasted to grow by 14% annually. In this environment, identifying undervalued stocks can be key for investors seeking opportunities that align with these promising growth prospects.

Source: Yahoo

6/25/2025

September S&P 500 E-Mini futures (ESU25) are trending up +0.16% this morning, extending yesterday’s gains, while investors await further testimony from Federal Reserve Chair Jerome Powell for clues on the rate outlook.

Source: Yahoo

6/24/2025

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +1.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.53%. September E-mini S&P futures (ESU25 ) are up +1.11%, and September E-mini Nasdaq futures...

Source: Yahoo

6/24/2025

A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.4%, S&P 500 +1.0%) on hopes the reported ceasefire between Israel and Iran will hold. This de-escalation in a volatile region helped to ease concerns about potential disruptions to global oil supplies, leading to a notable dip in crude oil prices.

Source: Yahoo

6/24/2025

DexCom Inc. stock outperforms competitors on strong trading day

Source: MarketWatch

6/24/2025

U.S. Health Secretary Robert F.Kennedy Jr. said on Tuesday that the Department of Health andHuman Services plans to launch an advertising campaign toencourage Americans to adopt wearable devices,...

Source: Finnhub

6/24/2025

Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects.

Source: Yahoo

6/24/2025

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared updates on its implantable glucose sensors.

Source: Yahoo

6/20/2025

DexCom Inc. stock underperforms Friday when compared to competitors

Source: MarketWatch

6/20/2025

DXCM rides on record patient growth and T2D access gains, but margin pressure and FDA scrutiny cloud the outlook.

Source: Yahoo

6/20/2025

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for people with Type 2 diabetes and companies debut new devices.

Source: Yahoo

6/18/2025

DexCom Inc. stock underperforms Wednesday when compared to competitors

Source: MarketWatch

6/18/2025

SAN DIEGO, June 18, 2025--DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable insights into the perceptions around diabetes technology from more than 400 healthcare professionals and people with Type 2 diabetes across the United States.

Source: Yahoo

6/18/2025

Severe adverse events, including seizure and loss of consciousness, were potentially linked to the issue, based on 56 reports Dexcom received.

Source: Yahoo

6/18/2025

Looking back on patient monitoring stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including DexCom (NASDAQ:DXCM) and its peers.

Source: Yahoo

6/17/2025

DexCom Inc. stock underperforms Tuesday when compared to competitors

Source: MarketWatch

6/17/2025

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Deutsche Bank upgraded Cisco (CSCO) to Buy from Hold with a price target of $73, up from $65. The firm sees improved visibility towards “durable” mid-single-digit growth in upcoming years for Cisco, with tailwinds from artificial intelligence, a Campus portfolio refresh, more favorable near-term compet

Source: Yahoo